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Association of thin glomerular basement membrane with other gb-
merutopathies. In the present study we assessed the prevalence of thin
gbomerular basement membrane (TGBM) in a large group of native
kidney biopsies done for evaluation of renal disease. TGBM was present
in 54 of 1078 biopsies (5%). In 12 of 54 biopsies (24%), TGBM was the
only abnormality present. In the remaining biopsies TGBM was associated
with other pathologic diagnoses. The overall prevalence of TGBM in this
series is comparable to previous population studies. TGBM is significantly
more common in patients with IgA nephropathy and mesangial prolifer-
ative glomerulonephritis. Compared to control patients, individuals with
TGBM were more likely to have a history of familial hematuria (14% vs.
43%, P = 0.02). Furthermore, examination of urinary sediments in first
degree relatives of patients with TGBM demonstrated microscopic hema-
tuna in 92% of families and, in those families, hematuria was present in 47
6% of relatives. In contrast, hematuria was discovered in 38% of
families of control patients, affecting 25 5% of relatives. In conclusion,
the presence of TGBM in a kidney biopsy is highly predictable for the
presence of familial microscopic hematuria, even in patients in whom
TGBM is associated with another glomerulopathy. The present data also
indicate that patients with TGBM nephropathy often have concomitant
IgA nephropathy and mesangial proliferative glomerulonephritis.
Thin glomerular basement membrane (TGBM) nephropathy is
an autosomal dominant disease characterized anatomically by the
presence of abnormal thinning of GBM and clinically by the
presence of familial benign hematuria [1]. TGBM nephropathy is
now recognized as a leading cause of microscopic hematuria in
both children and adults [2, 3] and is generally regarded as a
benign condition. TGBM is common, having been demonstrated
in 5 to 10% of normal kidneys from transplant donors [4].
The diagnosis of TGBM nephropathy is confounded by the fact
that TGBM can be demonstrated in other hereditary renal
diseases [5, 6] and in patients with acquired glomerular diseases
[7]. An additional issue, in regards to the diagnosis of TGBM
nephropathy, is the extent of GBM thinning. In TGBM nephrop-
athy GBM thinning is more often segmental than diffuse [1, 6, 8,
9]. Thus, it has been suggested that the diagnosis of TGBM
nephropathy should be based on the demonstration of an average
GBM width of less than 200 to 250 nm, based on multiple (up to
400) random measurements of GBM width [3, 4, 10, 11]. Unfor-
tunately, this diagnostic approach is not practical in a routine
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clinical setting. Given all of these considerations, TGBM ne-
phropathy, despite its frequency, is most likely an underdiagnosed
disease.
In the present study, we assessed a large number of native
kidney biopsies for the presence of TGBM. In our institution, all
native kidney biopsies are examined by electron microscopy, and
GBM width is routinely measured in selective photographs rep-
resentative of the glomerular morphology. The aim of the present
study was to: first, determine the prevalence of TGBM in patients
with renal pathology; second, to determine whether TGBM is
associated with other glomerular diseases; and third, to determine
whether the presence of TGBM in a biopsy, even when associated
with another glomerulopathy, predicts the presence of familial
hematuria.
Methods
Materials
The present study is based on a retrospective review of 1,250
native kidney biopsies performed at the Ohio State University
from 1983 to the beginning of 1993. All patients included in this
study were adults (>15 years old). All biopsies were examined by
light, immunofluorescence (IF) and electron microscopy (EM).
One hundred seventy-two biopsies were not considered for fur-
ther analysis because the tissue available for electron microscopy
was not adequate, either due to lack of glomeruli or the presence
of sclerotic glomeruli only. All biopsies containing at least one
glomerulus in the EM block were included in the present study.
As part of the routine EM evaluation of tissues, all glomeruli were
visualized under the microscope and all those glomerular areas
suspicious for pathology, including possible abnormalities in
GBM width, were photographed. Subsequently, measurements of
GBM width were done by described methods [3, 11] in those
selected photographs. The results of those GBM measurements
are routinely included in the final pathology report. For the
present studies, all biopsies containing areas of GBM less than
200 nm in width [11] were re-examined by light microscopy and
EM, and new EM photographs were obtained in four cases for
measurement of additional GBM segments and confirmation of
diagnosis. Biopsies that met the following criteria were included in
this study: (1) the presence of diffuse or segmental thin GBM with
a width of less than 200 nm; (2) the areas of thin GBM occupied
at least 50% of the filtration surface of particular capillaries; (3)
GBM thinning was demonstrable in more than 1 capillary; (4) to
exclude Alport's syndrome, we did not include biopsies with any
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evidence of GBM splitting or the presence of intramembranous
dense bodies [5].
Clinical parameters at presentation and follow-up clinical data
were obtained by chart review. In addition, we attempted to
contact all patients and controls to obtain additional historical
data and request urine samples. All patients with a family history
of deafness affecting more than one relative, and/or a family
history of renal failure, were excluded. All patients were contacted
and we requested sterile urine samples from patients and their
first degree relatives. Those midstream urine samples were col-
lected at home and mailed to us in sealed receptacles containing
a tablet of the preservative Stabilur (Cargille Laboratories, Cedar
Grove, New Jersey, USA). Upon arrival, all urine samples were
examined by Chemstrip (Boehringer Mannehaim Diagnostics,
Indianapolis, Indiana, USA) for the presence of protein, blood,
glucose, and white blood cells. Urine samples were centrifuged to
separate the urine sediment. Results of the Chemstrip were
recorded and each sample was given an identification number
which was used for labeling the microscopic slide containing the
urine sediment. Those slides were examined independently by two
investigators (FGS and MEF) who had no previous knowledge of
the individual's name or the results of Chemstrip test. Two groups
of control subjects are included in the study: (1) control patients
(N = 17), that is, individuals included in the biopsy series who
demonstrated glomerulonephritis, but had no GBM thinning in
the kidney biopsy. Control patients demonstrated, by kidney
biopsy, IgA nephropathy (N = 10), focal glomerulosclerosis
(FGS) (N = 5), or minimal change nephrotic syndrome (N = 2).
(2) Healthy controls (N = 20) were individuals with no history or
family history of kidney problems. Urine samples from patients,
relatives of patients, control patients, relatives of control patients,
and healthy controls were collected simultaneously. A total of 281
urine samples were evaluated. Those samples with evidence of
urinary tract infection (polymorphonuclear leukocytes and bacte-
ria in the urine sediment) were not included in the study. The
number of RBC encountered in each high power microscopic field
(x400) varies in each sediment and some fields contain 0 RBC
even in patients with microscopic hematuria. In the present study,
urine sediments containing a range of RBC/microscopic fields
greater that 0 to 2 were considered abnormal. This level of
hematuria is also used in our routine clinical practice, where all
urinary sediments are examined by a nephrologist. There was a
95% agreement in the interpretation of urinary sediment findings
between the two investigators examining urine sediments inde-
pendently.
Analysis of data
Results were analyzed by chi-square with a Fisher's exact test.
Results throughout the manuscript are expressed as means
standard error of the mean.
Results
011,078 biopsies studied, 54 (5%) met the diagnostic criteria of
TGBM nephropathy described above. These patients had a mean
age of 47 years (range from 14 to 85) and included 37 females and
17 males. The results of the light and IF microscopic evaluation of
these 54 biopsies are summarized in Table 1. Thirteen of the 54
biopsies (24%) demonstrated normal glomerular morphology by
light microscopy. The remaining biopsies demonstrated a variety
of pathologic abnormalities, as indicated on Table 1. When the
Table 1. Prevalence of TGBM in the population of patients undergoing
diagnostic native kidney biopsies
Pathologic diagnosis N'
Biopsies with
TGBM
Prevalence
%
All biopsies
No glomerular abnormalities
Mesangial proliferative GN
IgA nephropathy
1,078
42
95
83
54
13
12
10
5
31"
13"
12"
FGS 190 10 5
Otherc 9
Patients are grouped according to light and IF microscopic diagnosis.
aN = number of biopsiesbp < 0.01 compared to the prevalence of TGBM in all biopsies in this
series
° group includes 3 patients with SLE, 1 with ATN, 2 with crescentic
glomerulonephritis, 1 with T1'P, 1 patient with interstitial nephritis, and 1
biopsy containing insufficient tissue for light microscopic examination
prevalence of TGBM was considered for each disease category,
there was a significantly higher than predicted prevalence of
TGBM in patients with normal glomerular morphology by light
microscopy, patients with IgA nephropathy and patients with
mesangial proliferative glomerulonephritis. These differences in
the prevalence of TGBM among biopsies with glomerular diseases
remained significant even when those biopsies demonstrating
GBM abnormalities which could have obscured the presence of
TGBM were excluded from the analysis such as membranous
nephropathy and membranoproliferative glomerulonephritis. The
group of patients with mesangial proliferative glomerulonephritis
included five biopsies with negative immunofluorescence, three
with mesangial 1gM, and three with both 1gM and C3 staining of
the glomerular mesangium. Figure 1 demonstrates representative
EM photographs of normal and abnormally thin GBM in patients
with normal glomerular morphology and in a patient with IgA
nephropathy.
At the time of biopsy, all patients had microscopic hematuria
but none had a history of macroscopic hematuria. Table 2 displays
additional renal-related clinical parameters present at the time of
kidney biopsy in patients with TGBM. In general, patients with
normal glomerular morphology had a benign clinical presentation
and only one patient demonstrated an abnormally elevated serum
creatinine. Of interest, three patients with TGBM and normal
glomeruli were biopsied because microscopic hematuria was
discovered during their work up as potential kidney donors for
their children, all of whom suffered from congenital renal malfor-
mations.
Patients with TGBM and abnormal glomerular morphology
frequently presented with nephrotic range proteinuria, hyperten-
sion and/or renal insufficiency (Table 2). Seven patients with
TGBM progressed to end-stage renal failure. Among these, one
patient had initially normal glomerular morphology, two patients
had FGS, and four patients had IgA nephropathy.
Four patients had complaints of episodic severe flank pain and
carried the diagnosis of loin pain-hematuria syndrome. The
prevalence of other symptoms was not different between patients
with TGBM and controls.
Family history of hematuria was positive in 15 of 35 (43%)
patients with TGBM, and in 2 of 14 (14%) control patients (P =
0.02by Fisher's exact test). Urine samples were collected from 13
families of control patients (50%), and 26 families of patients with
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Table 2. Incidence (%) of renal-related clinical parameters in patients
with TGBM grouped according to their renal pathologic diagnosis
Diagnosis
Urine protein
>3 g/24 hr Hypertension
Serum creatinine
>1.5 mgldl
Normala 0% 30% 10%
Mesangial GN 50% 50% 25%
IgA nephropathy 50% 40% 40%
FGS 50% 63% 38%
Other (see Table 1) 75% 50% 86%
a Patients in this group had discernible glomerular abnormalities by
light and IF microscopybValues represent percent of patients
Table 3. Prevalence of hematuria in first degree relatives of patients
with TGBM and control patients with glomerular disease without
TGBM
Parameter
Control
patients
TGBM
patients P
Percent of patients who had 38% 92% <0.0001
positive family urines
Percent of first degree 25 5% 47 6% <0.0001
relatives with hematuria
a Statistical comparison, by chi-square (Fisher's exact test), between
control patients and TGBM patients
Fig. 1. Representative electron microscopic photomicrographs (magnifica-
tion 8,381 for all three pictures). (A) Normal glomerulus demonstrating
normal GBM width measuring from 298 to 441 nm; (B) TGBM in a
patient with normal glomerular morphology by light and IF microscopy. In
this particular biopsy GBM width was measured between 131 and 334 nm;
(C) TGBM in a patient with IgA nephropathy. Note electron dense
deposit (DD) and the variability in GBM width from very thin (GBM in
lower capillary loop GBM measured an average of 150 nm) to normal
width (see upper capillary loop).
TGBM (48% of patients). The distribution of pathologic diagno-
sis among these 26 TGBM probands was not different from that
demonstrated previously for the entire population of patients with
TGBM (Table 1). Urine samples from patients, relatives and
healthy controls were examined blindly. In urine samples mailed
to us by patients (proband), we demonstrated microscopic hema-
tuna in 78% of patients with TGBM, 62% of controls patients,
and in none of the urine samples from healthy controls. Results of
the examination of family urines is displayed in Table 3. One
hundred forty urine samples were collected from first degree
relatives of patients with TGBM (mean of 5 relatives per patient,
range from 2 to 12). In 92% of those families at least one first
grade relative demonstrated microscopic hematuria. In families
positive for microscopic hematuria, 47 6% of family members
were affected. Seventy-two urine samples were examined from
first degree relatives of control patients (mean 6 relatives per
patient, range from 3 to 11). In 38% of those families microscopic
hematuria was present in at least one relative. In those positive
families 25 5% of relatives were affected. Both the familial
prevalence of microscopic hematuria (92% vs. 38%), and the
percent of family members with hematuria (47% vs. 25%) were
significantly higher in patients with TGBM than in control pa-
tients (Table 3).
Discussion
In the present study we demonstrated that TGBM nephropathy
is a common finding in patients undergoing native kidney biopsies
for evaluation of renal pathology. The overall prevalence of
TGBM in the present study population is not different from that
previously reported in a study that used rigorous methods to
assess GBM thickness [4]. This finding suggests that the method
used to assess GBM width in the present study is sufficiently
sensitive to accurately identify the prevalence of TGBM nephrop-
athy. Additional support for the validity of our approach to
identify TGBM is that the diagnosis of TGBM in our patients was
associated with a high likelihood of discovering hematuria in first
degree relatives.
Based on the present observations, and in previous studies, we
propose that the diagnosis of TGBM nephropathy should be
based on the following criteria: (1) the presence of diffuse or
segmental GBM thinning in at least one glomerulus; (2) the
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absence of family history of deafness and/or renal failure; and (3)
in patients with thin GBM and another glomerulopathy, the
diagnosis of TGBM also requires the demonstration of micro-
scopic hematuria in first degree relatives. Indeed, in affected
families we have found a prevalence of hematuria of 47%,
consistent with an autosomal dominant mode of inheritance of
TGBM nephropathy [11.
The importance of the examination of family urines is exempli-
fied by the following observations. Previous studies have demon-
strated the presence of areas of TGBM in patients with acquired
glomerulopathies, and suggested that TGBM is a nonspecific
diagnostic finding [71. However, because those studies did not
include an examination of urine samples from patient's relatives,
we cannot exclude the possibility that those patients suffered from
two diseases: TGBM nephropathy and an acquired glomerulopa-
thy. Indeed, the findings of the present study will support this
possibility, because most patients with TGBM and another gb-
merulopathy had familial hematuria. This finding may not be
unexpected considering the high prevalence of TGBM nephrop-
athy and presuming, as it seems reasonable, that patients with
TGBM are not protected from other glomerular diseases. In fact,
the prevalence of TGBM in patients with FUS, the most common
diagnosis in our biopsy series, was not different from that encoun-
tered in the population as a whole. In contrast, the prevalence of
TGBM nephropathy was significantly higher in patients with IgA
nephropathy and mesangial proliferative glomerulonephritis sug-
gesting that patients with TGBM nephropathy are predisposed to
these glomerular diseases. A previous publication has described a
patient in whom TGBM nephropathy was associated with IgA
nephropathy [12]. It should be clarified that the association of
TGBM nephropathy with IgA nephropathy cannot fully explain
the familial prevalence of the latter disease [13]. Thus, we have
observed patients with familial IgA nephropathy in the absence of
TGBM.
In the present series, patients with TGBM nephropathy and
other glomerulopathies did not have a benign clinical course.
Previous studies have indicated the potential progression of
TGBM nephropathy into renal failure [14]. At the least, these
observations should discourage the interchangeable use of the
terms familial benign hematuria and TGBM nephropathy.
The demonstration of TGBM in a kidney biopsy has several
relevant clinical implications: (1) TGBM indicates the presence of
familial hematuria; (2) TGBM may predispose to other glomeru-
lopathies; and (3) in patients with TGBM nephropathy and
another gbomerulopathy, the former disease may confuse the
evaluation of the latter. For example, our series includes three
patients with SLE and TGBM nephropathy. In one particular
patient, the demonstration of red blood cell casts in the urine was
interpreted as indicating an active glomerular process and led to
the initiation of immunosuppressive therapy. However, a kidney
biopsy demonstrated the presence of TGBM nephropathy and the
absence of active lupus nephritis. Based on these clinical implica-
tions it is our recommendation that a routine evaluation of kidney
biopsies should include EM studies, Alternatively, in patients
whose biopsies demonstrate normal glomerular morphology, me-
sangial proliferative glomerulonephritis, or IgA nephropathy we
recommend an examination of urine samples in first degree
relatives.
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